Supplier |
Ace Therapeutics |
Product # |
NSC165 |
Pricing |
Inquiry
|
Product Size |
100 µg
|
Purity |
> 95 % as determined by SDS-PAGE
|
Product Type |
Proteins
|
Synonyms |
NF Protein, Human; NRCAML Protein, Human
|
Endotoxin |
< 1.0 EU per μg of the protein as determined by the LAL method
|
Activity |
Testing in progress
|
Protein Construction |
A DNA sequence encoding the human NFASC (O94856-12) (Met1-Gln939) was expressed with a C-terminal polyhistidine tag.
|
Accession# |
O94856-12
|
Expressed Host |
HEK293 Cells
|
Species |
Human
|
Predicted N Terminal |
Ile 25
|
Molecule Mass |
The recombinant human NFASC comprises 926 amino acids and has a predicted molecular mass of 104.4 kDa. The apparent molecular mass of the protein is approximately 114-119 kDa in SDS-PAGE under reducing conditions.
|
Formulation |
Lyophilized from sterile 20mM Tris, 150mM NaCl, 10% Glycerol, 5% trehalose, 0.02%Tween 20, pH8.5.Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
|
Shipping |
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
|
Stability & Storage |
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Reconstitution |
A hardcopy of datasheet with reconstitution instructions is sent along with the products. Please refer to it for detailed information.
|